摘要
目的:探究小儿肺炎支原体肺炎患儿采用阿奇霉素序贯疗法联合痰热清的治疗效果。方法:选取2018年3月-2019年3月笔者所在医院收治的74例小儿肺炎支原体肺炎患儿,通过简单随机分组法分为对照组和研究组,每组37例,分别采用阿奇霉素序贯疗法和阿奇霉素序贯疗法联合痰热清治疗。对比两组治疗前后IgA、CRP水平及不良反应发生率。结果:研究组治疗后IgA显著高于对照组,CRP显著低于对照组,差异均有统计学意义(P<0.05);研究组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:阿奇霉素序贯疗法联合痰热清在小儿肺炎支原体肺炎患儿中的应用效果较好,值得推广应用。
Objective:To investigate the therapeutic effect of Azithromycin sequential therapy combined with Tanreqing in the treatment of mycoplasma pneumoniae pneumonia in children.Method:A total of 74 children with mycoplasma pneumoniae pneumonia admitted to our hospital from March 2018 to March 2019 were selected and divided into the control group and the study group by simple random grouping method,37 cases in each group,and they were treated with Azithromycin sequential therapy and Azithromycin sequential therapy combined with Tanreqing,respectively.The levels of IgA and CRP before and after treatment and the incidence of adverse reactions were compared between the two groups.Result:After treatment,IgA in the study group was significantly higher than that of the control group,while CRP was significantly lower than that of the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the study group was lower than that of the control group,and the difference was statistically significant(P<0.05).Conclusion:Azithromycin sequential therapy combined with Tanreqing has a good effect in the treatment of children with mycoplasma pneumoniae pneumonia,which is worthy of popularization and application.
作者
刘鹏
LIU Peng(Linxi Hospital,the Affiliated Kailuan General Hospital,Tangshan 063000,China)
出处
《中外医学研究》
2020年第7期145-146,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
小儿肺炎支原体肺炎
阿奇霉素
痰热清
血清指标
不良反应
Mycoplasma pneumoniae pneumonia in children
Azithromycin
Tanreqing
Serum indexes
Adverse reaction
